Furthermore, in vivo assays utilizing two murine HCC models demonstrated that pharmacological inhibition of NUPR1 significantly suppressed tumor growth, accompanied by increased M1 macrophage polarization and enhanced CD8+ T cell activity. This evidence concerns the gene NUPR1 and hepatocellular carcinoma.